 |
|
|
| |
Virologic Failure with Cabotegravir-Rilpivirine Injections: A Single-Site Experience; independent infusion center
|
| |
| |
CROI 2024 March 3-6 Denver
Shivanjali Shankaran, MD, Laura Hernandez-Guarin, MD, Neel Jhobalia PharmD, Beverly Sha, MD, Mariam Aziz, MD
75 undetectable patients (UD, VL <40 copies/ml) were switched to CAB-RPV. 10 received their injections at an independent infusion center (IC) with trained injectors. 65 received injections at our clinic. Two of ten patients at IC and 1 of 65 patients at our clinic developed VF (4%).
|
| |
|
|
|
|
|
